Deqiang Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 35
- Cancer Immunotherapy and Biomarkers 14
- Lung Cancer Research Studies 7
-
- Epigenetics and DNA Methylation 6
- Co-authors
- Xiaoqin Li (22 shared papers)Fen Xiong (7 shared papers)Yongqian Shu (11 shared papers)Xiao Yuan (4 shared papers)Xu Wang (1 shared paper)Ting Zhu (1 shared paper)Wenwen Xue (1 shared paper)Minmin Fan (1 shared paper)
- Journals
- Frontiers in Immunology (6 papers)Frontiers in Oncology (6 papers)Journal of Clinical Oncology (5 papers)OncoTargets and Therapy (3 papers)Journal of Medical Virology (3 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Deqiang Wang
92 papers receiving 1.1k citations
Deqiang Wang's Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 374
- Oncology 325
- Pulmonary and Respiratory Medicine 320
- Molecular Biology 506
- Immunology 136
Countries citing papers authored by Deqiang Wang
This map shows the geographic impact of Deqiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deqiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deqiang Wang more than expected).
Fields of papers citing papers by Deqiang Wang
This network shows the impact of papers produced by Deqiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deqiang Wang. The network helps show where Deqiang Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Deqiang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers Hit paper breakdown → | 2022 | 126 |
| 2 | 2018 | 91 | |
| 3 | 2021 | 75 | |
| 4 | 2023 | 47 | |
| 5 | 2016 | 42 | |
| 6 | 2022 | 32 | |
| 7 | 2023 | 29 | |
| 8 | 2017 | 28 | |
| 9 | 2021 | 26 | |
| 10 | 2015 | 25 | |
| 11 | 2014 | 24 | |
| 12 | 2024 | 24 | |
| 13 | 2015 | 23 | |
| 14 | 2022 | 22 | |
| 15 | 2011 | 21 | |
| 16 | 2021 | 21 | |
| 17 | 2023 | 19 | |
| 18 | 2015 | 18 | |
| 19 | 2021 | 17 | |
| 20 | 2020 | 16 |
About Deqiang Wang
Deqiang Wang is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 94 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Gastric Cancer Management and Outcomes (12 papers), Genetic factors in colorectal cancer (10 papers), Lung Cancer Research Studies (7 papers), Epigenetics and DNA Methylation (6 papers), Ferroptosis and cancer prognosis (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Cancer Research (374 citations), Oncology (325 citations), Pulmonary and Respiratory Medicine (320 citations), Molecular Biology (506 citations) and Immunology (136 citations). Deqiang Wang has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Xiaoqin Li, Fen Xiong, Yongqian Shu, Xiao Yuan, Xu Wang, Ting Zhu, Wenwen Xue, Minmin Fan, Yan Shen and Xiaofeng Chen. Their work appears in journals such as Frontiers in Immunology, Frontiers in Oncology, Journal of Clinical Oncology, OncoTargets and Therapy and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.